News & Updates

(Reuters) -The S&P 500 and the Nasdaq were lower on Monday after U.S. President Donald Trump rekindled worries about the fallout of a global trade war by introducing new tariffs, while focus remained on the Federal Reserve's monetary policy decision later this week. On Sunday, Trump announced a 100% tariff on movies produced outside the U.S. but offered little clarity on how the levies would be implemented. Several movie and television production companies took a hit.

Despite the billionaire’s frugal ways, his presence pumped up the local economy, drawing tourists and packing annual conventions.

The key to generating a lot of dividend income is building up your balance. Investing in a top exchange-traded fund every week can be a good habit to start right away. Finding money to invest in the stock market can be challenging, especially amid inflation and tariffs.

Warren Buffett shares his insights on market volatility, trade and U.S. deficit. Discover ETF strategies inspired by his wisdom to navigate today's economic landscape and build long-term wealth.

Wall Street kicks off May on a strong note due to strong jobs data and trade optimism. Tech leads the charge.

The S&P 500 just rose for nine consecutive days for the first time since November 2004. Stock performance following such winning streaks in the past has been a mixed bag. What happens next with the S&P 500 will likely depend on what happens with U.S. trade policy.

Warren Buffett plans to step down as Berkshire Hathaway’s CEO at the end of 2025. Buffett and his co-investment managers have struggled to put cash to work in stocks in recent years. Berkshire stock currently trades at 1.8 times book value, its most expensive valuation in 15 years.

Two industry-leading AI stocks are historically cheap and begging to be bought, while another highflier -- up more than 1,700% since 2023 began -- won't live up to the hype surrounding it.

Aerospace and defense technology solutions provider Astronics Corporation (NASDAQ:ATRO) will be reporting results tomorrow afternoon. Here’s what to look for.

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting earnings tomorrow afternoon. Here’s what to look for.